GNH USA

Europe — EMA

Icalziss

GNH USA supplies Icalziss (Calcium Chloride), a calcium salt for extracorporeal use to correct hypocalcemia and calcium deficiency. Request a quote today.

Calcium Chloride Dihydrate

Request sourcing

1
Pack/s

What is Calcium Chloride Dihydrate?

Calcium chloride dihydrate, the active ingredient in Icalziss, is a calcium salt presented as a sterile solution for extracorporeal use. It helps restore extracellular calcium concentrations in patients with hypocalcemia or calcium deficiency, particularly in settings such as dialysis or surgery. It is indicated for rapid correction of calcium deficits and is compatible with standard dialysis circuits.

GNH USA supplies Icalziss as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, adhering to EU quality standards and providing reliable logistics for clinical and institutional customers.

What is Calcium Chloride Dihydrate used for?

Icalziss is used as an electrolyte replenisher to address conditions associated with low calcium levels.

- Hypocalcemia: rapid increase of serum calcium to normal range. - Calcium deficiency: replenishment of extracellular calcium during dialysis or prolonged fasting. - Peri‑operative calcium management: maintenance of calcium homeostasis during surgical procedures.

What are the side effects of Calcium Chloride Dihydrate?

Calcium chloride administration may be associated with adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Hypercalcemia: transient elevation of serum calcium causing mild symptoms. - Hypotension: drop in blood pressure during rapid infusion. - Nausea or vomiting: gastrointestinal discomfort. - Muscle cramps or tingling: neuromuscular irritation.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm due to calcium overload. - Tissue necrosis: severe local injury if the solution extravasates. - Anaphylactic reaction: rare severe allergic response.

What precautions apply to Calcium Chloride Dihydrate?

When using Icalziss, clinicians should observe specific safety measures. - Monitor serum calcium: check levels before, during, and after infusion. - Adjust infusion rate: avoid rapid bolus to reduce cardiovascular stress. - Contraindicated in severe hypercalcemia: do not administer when calcium is already elevated. - Use with caution in renal impairment: altered calcium handling may require dose modification. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

What does Calcium Chloride Dihydrate interact with?

Calcium chloride can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Digoxin: increased risk of arrhythmia due to altered calcium homeostasis. - Loop diuretics: enhanced calcium loss may counteract therapeutic effect. - Bisphosphonates: additive calcium load can precipitate hypercalcemia.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: reduced calcium excretion may raise serum levels. - Vitamin D analogs: synergistic increase in calcium absorption. - Calcium‑containing antacids: cumulative calcium effect may require monitoring.

Frequently asked questions

What is Icalziss used for?+
Icalziss is an electrolyte replenisher containing calcium chloride dihydrate. It is used to correct low calcium levels (hypocalcemia) and treat calcium deficiency, especially in patients undergoing dialysis or those who require rapid restoration of extracellular calcium.
How does calcium chloride dihydrate work in Icalziss?+
The calcium chloride dihydrate in Icalziss dissociates to release calcium ions (Ca2+). These ions raise extracellular calcium concentrations, supporting cardiac, neuromuscular and coagulation functions and helping restore normal physiological processes that depend on calcium.
What is the usual dose of Icalziss?+
The dose of Icalziss is determined by the prescribing clinician based on the patient’s serum calcium level, clinical condition, and the intended route of administration. Specific dosing regimens are not provided here and should follow the prescriber’s instructions.
Is Icalziss safe during pregnancy or breastfeeding?+
Safety data for Icalziss in pregnancy or lactation are limited. Use only if the potential benefit justifies any potential risk to the fetus or infant, and decisions should be made by the treating physician in consultation with the patient.
How do I order Icalziss from GNH USA?+
To order Icalziss, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does Icalziss compare with other calcium salts?+
Icalziss provides calcium chloride dihydrate, which delivers calcium ions more rapidly than calcium gluconate or calcium carbonate. This makes it suitable for acute correction of calcium deficits, whereas other salts may be used for slower, oral supplementation or for patients with different tolerance profiles.
What are the storage requirements for Icalziss?+
Store Icalziss at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is sealed when not in use.
How is Icalziss administered?+
Icalziss is supplied as a sterile solution for extracorporeal administration, typically infused into a dialysis circuit or administered intravenously under controlled conditions. The exact method and rate are determined by the healthcare professional based on the clinical scenario.
What are the most serious risks associated with Icalziss?+
Serious risks include cardiac arrhythmias, severe hypercalcemia, tissue necrosis if the solution extravasates, and rare anaphylactic reactions. Continuous monitoring of serum calcium and cardiovascular status is essential during and after administration.
Who should not receive Icalziss?+
Icalziss should not be given to patients with known severe hypercalcemia, uncontrolled cardiac arrhythmias, or hypersensitivity to calcium chloride. Clinicians should also exercise caution in patients with renal impairment or those receiving interacting medications.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Calcium Chloride Dihydrate
Route
Extracorporeal Use
Manufacturer
Vantive Belgium
Origin
EU

Related products